About Index Trending news
Analyze
Top 50 Pricing
Xencor

Xencor

Xencor

Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.

Elsewhere

Also headquartered in Monrovia

Alexa global traffic share

Latest funding
Venture capital (Series E)
$15,000,000
Employees

Team size

50+

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Xencor makes some noise.